Kai G. Kahl

2.2k total citations
60 papers, 1.2k citations indexed

About

Kai G. Kahl is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pathology and Forensic Medicine. According to data from OpenAlex, Kai G. Kahl has authored 60 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 14 papers in Clinical Psychology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Kai G. Kahl's work include Tryptophan and brain disorders (7 papers), Schizophrenia research and treatment (6 papers) and Treatment of Major Depression (5 papers). Kai G. Kahl is often cited by papers focused on Tryptophan and brain disorders (7 papers), Schizophrenia research and treatment (6 papers) and Treatment of Major Depression (5 papers). Kai G. Kahl collaborates with scholars based in Germany, United States and Spain. Kai G. Kahl's co-authors include Ulrich Schweiger, Sebastian Rudolf, L. Dibbelt, Thomas Hillemacher, Helge Frieling, Andreas Kordon, Beate M. Stoeckelhuber, Fritz Hohagen, Peter Rieckmann and Christoph U. Correll and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Behaviour Research and Therapy.

In The Last Decade

Kai G. Kahl

55 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kai G. Kahl Germany	19	342	342	216	161	151	60	1.2k
Thelma Beatriz González‐Castro Mexico	20	433 1.3×	228 0.7×	217 1.0×	213 1.3×	144 1.0×	134	1.5k
María Lilia López‐Narváez Mexico	21	442 1.3×	244 0.7×	210 1.0×	200 1.2×	142 0.9×	122	1.5k
Erika F.H. Saunders United States	24	327 1.0×	719 2.1×	340 1.6×	106 0.7×	201 1.3×	86	1.7k
Eugene Cassidy Ireland	20	320 0.9×	479 1.4×	220 1.0×	114 0.7×	162 1.1×	54	1.3k
Chadi A. Calarge United States	24	219 0.6×	633 1.9×	207 1.0×	324 2.0×	93 0.6×	72	1.6k
Jochen Kindler Switzerland	22	193 0.6×	492 1.4×	234 1.1×	157 1.0×	139 0.9×	88	1.7k
Patrick Hardy France	21	410 1.2×	326 1.0×	157 0.7×	166 1.0×	102 0.7×	47	1.4k
Dalibor Karlović Croatia	19	272 0.8×	226 0.7×	333 1.5×	87 0.5×	301 2.0×	93	1.0k
Ricard Navinés Spain	23	295 0.9×	278 0.8×	349 1.6×	185 1.1×	252 1.7×	57	1.5k
Panagiotis Ferentinos Greece	22	283 0.8×	519 1.5×	139 0.6×	125 0.8×	42 0.3×	116	1.5k

Countries citing papers authored by Kai G. Kahl

Since Specialization

Citations

This map shows the geographic impact of Kai G. Kahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai G. Kahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai G. Kahl more than expected).

Fields of papers citing papers by Kai G. Kahl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai G. Kahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai G. Kahl. The network helps show where Kai G. Kahl may publish in the future.

Co-authorship network of co-authors of Kai G. Kahl

This figure shows the co-authorship network connecting the top 25 collaborators of Kai G. Kahl. A scholar is included among the top collaborators of Kai G. Kahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai G. Kahl. Kai G. Kahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stapel, Britta, et al.. (2024). Remission from depression is associated with improved quality of life and preserved exercise capacity in adults with congenital heart disease. Frontiers in Cardiovascular Medicine. 11. 1418342–1418342. 1 indexed citations

Jahn, Kirsten, Olaf Krause, Stefan Bleich, et al.. (2023). Determinants of severe QTc prolongation in a real-world gerontopsychiatric setting. Frontiers in Psychiatry. 14. 1 indexed citations

Stapel, Britta, Ivo Heitland, Ralf Lichtinghagen, et al.. (2022). Cardiovascular risk in bipolar disorder – A case for the hypothalamus-pituitary-adrenal axis?. Journal of Affective Disorders. 324. 410–417. 2 indexed citations

Khaw, Pearly, Viet Do, Karen Lim, et al.. (2021). Radiotherapy Quality Assurance in the PORTEC-3 (TROG 08.04) Trial. Clinical Oncology. 34(3). 198–204. 2 indexed citations

Kahl, Kai G.. (2018). Direct and indirect effects of psychopharmacological treatment on the cardiovascular system. Hormone Molecular Biology and Clinical Investigation. 36(1). 19 indexed citations

Toto, Sermin, Wolfgang Sperling, Thomas Hillemacher, et al.. (2018). S100B, Homocysteine, Vitamin B12, Folic Acid, and Procalcitonin Serum Levels in Remitters to Electroconvulsive Therapy: A Pilot Study. Disease Markers. 2018. 1–8. 12 indexed citations

Martı́nez-Raga, José, Mario Amore, Guido Di Sciascio, et al.. (2018). 1st International Experts’ Meeting on Agitation: Conclusions Regarding the Current and Ideal Management Paradigm of Agitation. Frontiers in Psychiatry. 9. 54–54. 31 indexed citations

Jung, Seon Yeop, et al.. (2016). Supplementary Material for: The New Hamburg-Hannover Agitation Scale in Clinical Samples: Manifestation and Differences of Agitation in Depression, Anxiety, and Borderline Personality Disorder. Figshare.

Kleimann, Alexandra, Alexandra Kotsiari, Wolfgang Sperling, et al.. (2014). BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy. Journal of Neural Transmission. 122(6). 925–928. 56 indexed citations

10.

Scharnholz, Barbara, Maria Gilles, Florian Lederbogen, et al.. (2013). Do depressed patients without activation of the hypothalamus–pituitary–adrenal (HPA) system have metabolic disturbances?. Psychoneuroendocrinology. 39. 104–110. 17 indexed citations

11.

Greggersen, Wiebke, Sebastian Rudolf, Eva Faßbinder, et al.. (2010). Pain complaints in a sample of psychiatric inpatients. General Hospital Psychiatry. 32(5). 509–513. 3 indexed citations

12.

Schweiger, Ulrich, Wiebke Greggersen, Sebastian Rudolf, et al.. (2008). Disturbed Glucose Disposal in Patients With Major Depression; Application of the Glucose Clamp Technique. Psychosomatic Medicine. 70(2). 170–176. 34 indexed citations

13.

Kahl, Kai G., Wiebke Greggersen, Sebastian Rudolf, et al.. (2006). Bone Mineral Density, Bone Turnover, and Osteoprotegerin in Depressed Women With and Without Borderline Personality Disorder. Psychosomatic Medicine. 68(5). 669–674. 58 indexed citations

14.

Kahl, Kai G., Susanne Bens, Sebastian Rudolf, et al.. (2005). Cortisol, the Cortisol-Dehydroepiandrosterone Ratio, and Pro-Inflammatory Cytokines in Patients with Current Major Depressive Disorder Comorbid with Borderline Personality Disorder. Biological Psychiatry. 59(7). 667–671. 79 indexed citations

15.

Kahl, Kai G., Sebastian Rudolf, L. Dibbelt, et al.. (2004). Decreased osteoprotegerin and increased bone turnover in young female patients with major depressive disorder and a lifetime history of anorexia nervosa. Osteoporosis International. 16(4). 424–429. 22 indexed citations

16.

Kahl, Kai G., Harald Schmidt, Stefan Jung, et al.. (2004). Experimental autoimmune encephalomyelitis in mice with a targeted deletion of the inducible nitric oxide synthase gene: increased T-helper 1 response. Neuroscience Letters. 358(1). 58–62. 27 indexed citations

17.

Kahl, Kai G., Sebastian Rudolf, Beate M. Stoeckelhuber, et al.. (2004). Bone Mineral Density, Markers of Bone Turnover, and Cytokines in Young Women With Borderline Personality Disorder With and Without Comorbid Major Depressive Disorder. American Journal of Psychiatry. 162(1). 168–174. 71 indexed citations

18.

Kahl, Kai G., Peter Trillenberg, Andreas Kordon, et al.. (2004). Therapie der Clozapin-induzierten Hypersalivation mit Botulinum-Toxin B. Der Nervenarzt. 76(2). 205–208. 4 indexed citations

19.

Kordon, Andreas, et al.. (2004). Clinical outcome in patients with obsessive-compulsive disorder after discontinuation of SRI treatment: results from a two–year follow–up. European Archives of Psychiatry and Clinical Neuroscience. 255(1). 48–50. 26 indexed citations

20.

Kretzschmar, Titus, et al.. (1991). Characterization of the C5a Receptor on Guinea Pig Platelets. Immunobiology. 183(5). 418–432. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact